Anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment: Prevalence, etiology, and behavioral interventions

1988 ◽  
Vol 8 (5) ◽  
pp. 517-556 ◽  
Author(s):  
Gary R. Morrow ◽  
Patricia L. Dobkin
Keyword(s):  
Cancer Patients ◽  
Behavioral Interventions ◽  
Nausea And Vomiting ◽  
Chemotherapy Treatment ◽  
Anticipatory Nausea ◽  
Treatment Prevalence ◽  
Anticipatory Nausea And Vomiting

Clinical characteristics associated with the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment.

1984 ◽  
Vol 2 (10) ◽  
pp. 1170-1176 ◽  
Author(s):  
G R Morrow
Keyword(s):  
Side Effects ◽  
Cancer Patients ◽  
Nausea And Vomiting ◽  
Cancer Center ◽  
Chemotherapy Treatment ◽  
Anticipatory Nausea ◽  
Clinical Control ◽  
Chemotherapy Side Effects ◽  
Anticipatory Nausea And Vomiting ◽  
The University

Approximately one in four patients experiences nausea and/or vomiting in anticipation of a chemotherapy treatment by the time of their fourth treatment cycle. Anticipatory nausea and vomiting is a prevalent problem of clinical significance in the total management of chemotherapy side effects. While refractory to standard antiemetic treatment, anticipatory nausea and vomiting has been successfully treated with behavioral approaches such as systemic desensitization. The present study was designed to identify the characteristics of patients at high risk for developing anticipatory side effects. Early identification of cancer patients prone to developing anticipatory side effects could lead to preventive measures. One hundred seventy-six consecutive ambulatory patients with histologically confirmed cancer who were being treated at three geographically separate hospitals of the University of Rochester Cancer Center were studied at the time of their fourth chemotherapy treatment. Patients found to experience anticipatory nausea and vomiting were significantly more likely (P less than .001) to have four or more of the following characteristics than patients who did not report anticipatory side effects: (1) less than 50 years of age; (2) the experience of nausea and/or vomiting after their last chemotherapy treatment; (3) a description of nausea after the last treatment as "moderate, severe, or intolerable"; (4) a description of vomiting after the last treatment as "moderate, severe, or intolerable"; (5) the reporting of the side effect "warm or hot all over" after their last treatment; (6) a susceptibility to motion sickness; (7) the experience of "sweating after their last treatment"; (8) and the experience of "generalized weakness after their last chemotherapy treatment." Results support a view that anticipatory side effects are conditioned and point to practical interventions for their clinical control.

scholarly journals Behavioral Interventions in Treating Anticipatory Nausea and Vomiting

2007 ◽  
Vol 5 (1) ◽  
pp. 44-50 ◽  
Author(s):  
Colmar Figueroa-Moseley ◽  
Pascal Jean-Pierre ◽  
Joseph A. Roscoe ◽  
Julie L. Ryan ◽  
Sadhna Kohli ◽  
...  
Keyword(s):  
Behavioral Interventions ◽  
Relaxation Training ◽  
Muscle Relaxation ◽  
Progressive Muscle Relaxation ◽  
Nausea And Vomiting ◽  
Alternative Methods ◽  
Anticipatory Nausea ◽  
Anticipatory Nausea And Vomiting ◽  
Chemotherapy Patients ◽  
Type 3

Anticipatory nausea and vomiting (ANV) is associated with a significant reduction in the quality of life for many chemotherapy patients. The use of 5-hydroxytryptamine type 3 receptor antagonists provides some relief for chemotherapy-induced nausea and vomiting, but does not seem to control ANV. Nonpharmacologic approaches, which include behavioral interventions, may provide the greatest promise in relieving symptoms. Little evidence supports the use of complementary and alternative methods, such as acupuncture and acupressure, in relieving ANV. Behavioral interventions, especially progressive muscle relaxation training and systematic desensitization, should be considered important methods for preventing and treating ANV.

Anticipatory Nausea and Vomiting Among Ovarian, Lymphoma, and Breast Cancer Patients Receiving Chemotherapy: Implications for Behavioural Treatment

1992 ◽  
Vol 9 (1) ◽  
pp. 25-31
Author(s):  
Peter W. Dunne ◽  
Matthew R. Sanders ◽  
John H. Kearsley
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Nausea And Vomiting ◽  
Future Research ◽  
Breast Cancer Patients ◽  
Anticipatory Nausea ◽  
Anticipatory Anxiety ◽  
Behavioural Treatment ◽  
Anticipatory Nausea And Vomiting

Cancer patients undergoing chemotherapy frequently experience anticipatory distress before treatment sessions. Eighty-six cancer patients (ovarian, lymphoma and breast) were assessed to determine the prevalence of anticipatory nausea and vomiting (ANV). Approximately one patient in three reported anticipatory nausea (AN), and of these 6 also experienced anticipatory vomiting (AV). Several patients reported anticipatory anxiety without any sensation of nausea. Clinically the notion of anticipatory distress may be more fruitful so that the problem of pretreatment anxiety is also addressed. Generally, AN was rated as moderate or worse in severity, occurred fairly consistently, and often began well before arrival at hospital on treatment day. It is suggested that future research should endeavour to link more closely the topography of the problem and the intervention techniques employed, as well as evaluating a broader range of possible interventions.

Anticipatory nausea and vomiting in cancer patients.

1991 ◽  
Vol 59 (6) ◽  
pp. 894-898 ◽  
Author(s):  
Gerd Kvale ◽  
Kenneth Hugdahl ◽  
Arve Asbjørnsen ◽  
Bengt Rosengren ◽  
Knut Lote ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Nausea And Vomiting ◽  
Anticipatory Nausea ◽  
Anticipatory Nausea And Vomiting
Sign in / Sign up

Export Citation Format

Share Document